News Room

Follow:
55538 Articles

Shuttle Pharma Gets FDA Letter With Positive Feedback for Ropidoxuridine

By Chris Wack Shuttle Pharmaceuticals has received positive written responses to questions submitted for a Type B pre-Investigational New Drug

Bezos’s Blue Origin names former Amazon executive as CEO -internal email

© Reuters. Billionaire American businessman Jeff Bezos walks with Blue Origin's President and CEO Bob Smith after Bezos flew on

Sam Bankman-Fried’s Legal Team Once Again Files for Temporary Release

The defense team representing Sam Bankman-Fried has renewed their plea for his temporary release ahead of the highly anticipated trial. The

ConocoPhillips: OPEC+ Supply Cuts Translate To Profit Upside (NYSE:COP)

ConocoPhillips (NYSE:COP) is an attractive energy play for investors with an above-average risk-tolerance after OPEC+ countries Saudi Arabia and Russia

Santander ditched EY as financial crime consultant over alleged failings

Receive free EY updatesWe’ll send you a myFT Daily Digest email rounding up the latest EY news every morning.EY agreed

Scynexis Shares Slide Premarket on Brexafemme Recall, Study Hold >SCYX

By Colin Kellaher Shares of Scynexis tumbled in premarket trading Monday after the biotechnology company said it is recalling its

Your one-stop resource for medical news and education.

Your one-stop resource for medical news and education.